The carboxy terminal domain of RNA polymerase II and alternative splicing.

Alternative splicing is controlled by cis-regulatory sequences present in the pre-mRNA and their cognate trans-acting factors, as well as by its coupling to RNA polymerase II (pol II) transcription. A unique feature of this polymerase is the presence of a highly repetitive carboxy terminal domain (CTD), which is subject to multiple regulatory post-translational modifications. CTD phosphorylation events affect the transcriptional properties of pol II and the outcome of co-transcriptional alternative splicing by mediating the effects of splicing factors and by modulating transcription elongation rates. Here, we discuss various examples of involvement of the CTD in alternative splicing regulation as well as the current methodological limitations in deciphering the detailed mechanisms of this process.

[1]  I. Graham,et al.  Effects of RNA secondary structure on alternative splicing of Pre-mRNA: Is folding limited to a region behind the transcribing RNA polymerase? , 1988, Cell.

[2]  A. Kornblihtt.  Coupling transcription and alternative splicing. , 2007, Advances in experimental medicine and biology.

[3]  J. Ahringer,et al.  Differential chromatin marking of introns and expressed exons by H3K36me3 , 2008, Nature Genetics.

[4]  Dirk Eick,et al.  Serine-7 of the RNA Polymerase II CTD Is Specifically Required for snRNA Gene Expression , 2007, Science.

[5]  J. Manley,et al.  Phosphorylated RNA polymerase II stimulates pre-mRNA splicing. , 1999, Genes & development.

[6]  K. Neugebauer,et al.  Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells , 2006, Nature Structural &Molecular Biology.

[7]  A. Kornblihtt,et al.  The connection between splicing and cancer , 2006, Journal of Cell Science.

[8]  A. Kornblihtt,et al.  A slow RNA polymerase II affects alternative splicing in vivo. , 2003, Molecular cell.

[9]  M. Garcia-Blanco,et al.  MAZ Elements Alter Transcription Elongation and Silencing of the Fibroblast Growth Factor Receptor 2 Exon IIIb* , 2004, Journal of Biological Chemistry.

[10]  Francisco E. Baralle,et al.  Genomic variants in exons and introns: identifying the splicing spoilers , 2004, Nature Reviews Genetics.

[11]  T. Cooper,et al.  Alternative splicing in disease. , 2007, Advances in experimental medicine and biology.

[12]  Y. Osheim,et al.  Splice site selection, rate of splicing, and alternative splicing on nascent transcripts. , 1988, Genes & development.

[13]  M. Wickens,et al.  The C-terminal domain of RNA polymerase II couples mRNA processing to transcription , 1997, Nature.

[14]  S. Szostek,et al.  Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. , 2006, Genes & development.

[15]  Daniel F Tardiff,et al.  In vivo commitment to yeast cotranscriptional splicing is sensitive to transcription elongation mutants. , 2006, Genes & development.

[16]  A. Kornblihtt,et al.  Promoter Architecture Modulates CFTR Exon 9 Skipping* , 2003, The Journal of Biological Chemistry.

[17]  Christoforos Nikolaou,et al.  Nucleosome positioning as a determinant of exon recognition , 2009, Nature Structural &Molecular Biology.

[18]  X. Darzacq,et al.  In vivo dynamics of RNA polymerase II transcription , 2007, Nature Structural &Molecular Biology.

[19]  S. Buratowski,et al.  Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing. , 2004, Molecular cell.

[20]  B. Gómez-González,et al.  Genome instability: a mechanistic view of its causes and consequences , 2008, Nature Reviews Genetics.

[21]  D. Black,et al.  Co-transcriptional splicing of constitutive and alternative exons. , 2009, RNA.

[22]  Michael R Green,et al.  Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. , 2005, Molecular cell.

[23]  B. O’Malley,et al.  CoAA, a Nuclear Receptor Coactivator Protein at the Interface of Transcriptional Coactivation and RNA Splicing , 2004, Molecular and Cellular Biology.

[24]  A. Kornblihtt,et al.  RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20 , 2006, Nature Structural &Molecular Biology.

[25]  J. Ahearn,et al.  A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase II. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Manley,et al.  Pin1 modulates RNA polymerase II activity during the transcription cycle. , 2007, Genes & development.

[27]  K. J. Hertel,et al.  Linking Splicing to Pol II Transcription Stabilizes Pre-mRNAs and Influences Splicing Patterns , 2006, PLoS biology.

[28]  D. Eick,et al.  Conditional Expression of RNA Polymerase II in Mammalian Cells , 2000, The Journal of Biological Chemistry.

[29]  Xiang-Dong Fu,et al.  ASF/SF2-Regulated CaMKIIδ Alternative Splicing Temporally Reprograms Excitation-Contraction Coupling in Cardiac Muscle , 2005, Cell.

[30]  J. Manley,et al.  Pinning Down Transcription: Regulation of RNA Polymerase II Activity During the Cell Cycle , 2004, Cell cycle.

[31]  G. Orphanides,et al.  A Human RNA Polymerase II Complex Containing Factors That Modify Chromatin Structure , 1998, Molecular and Cellular Biology.

[32]  K. Neugebauer,et al.  Cotranscriptional spliceosome assembly occurs in a stepwise fashion and requires the cap binding complex. , 2005, Molecular cell.

[33]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[34]  R. Bronson,et al.  SRp38 regulates alternative splicing and is required for Ca(2+) handling in the embryonic heart. , 2009, Developmental cell.

[35]  K. Jones,et al.  The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation. , 2008, Genes & development.

[36]  G. Ast,et al.  Different levels of alternative splicing among eukaryotes , 2006, Nucleic acids research.

[37]  Peter J. Shepard,et al.  The SR protein family , 2009, Genome Biology.

[38]  M. Assanah,et al.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.

[39]  T. Misteli,et al.  RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo. , 1999, Molecular cell.

[40]  M. Yaniv,et al.  The human SWI/SNF subunit Brm is a regulator of alternative splicing , 2006, Nature Structural &Molecular Biology.

[41]  B. Blencowe,et al.  Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage. , 2004, RNA.

[42]  B. Graveley.  Alternative splicing: regulation without regulators , 2009, Nature Structural &Molecular Biology.

[43]  T. Cooper,et al.  Pre-mRNA splicing and human disease. , 2003, Genes & development.

[44]  W. G. Kelly,et al.  RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. , 1993, The Journal of biological chemistry.

[45]  A. Kornblihtt,et al.  First come, first served revisited: factors affecting the same alternative splicing event have different effects on the relative rates of intron removal. , 2010, RNA.

[46]  D. Bentley,et al.  Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD. , 2001, Genes & development.

[47]  D. Eick,et al.  Molecular evolution of the RNA polymerase II CTD. , 2008, Trends in genetics : TIG.

[48]  A. Kornblihtt,et al.  Antagonistic effects of T‐Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing , 2001, The EMBO journal.

[49]  Manuel de la Mata,et al.  Control of alternative splicing through siRNA-mediated transcriptional gene silencing , 2009, Nature Structural &Molecular Biology.

[50]  A. Krainer,et al.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.

[51]  S. Buratowski.  Progression through the RNA polymerase II CTD cycle. , 2009, Molecular cell.

[52]  A. Kornblihtt,et al.  Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.

[53]  Dirk Eick,et al.  Transcribing RNA Polymerase II Is Phosphorylated at CTD Residue Serine-7 , 2007, Science.

[54]  S. Shuman,et al.  Structure, mechanism, and evolution of the mRNA capping apparatus. , 2001, Progress in nucleic acid research and molecular biology.

[55]  M. Alló,et al.  Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing , 2009, Proceedings of the National Academy of Sciences.

[56]  P. Cramer,et al.  Structural Basis of Transcription: RNA Polymerase II at 2.8 Ångstrom Resolution , 2001, Science.

[57]  Danny Reinberg,et al.  Histones: annotating chromatin. , 2009, Annual review of genetics.

[58]  P Cramer,et al.  Functional association between promoter structure and transcript alternative splicing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Padgett,et al.  Rates of in situ transcription and splicing in large human genes , 2009, Nature Structural &Molecular Biology.

[60]  Shona Murphy,et al.  Cracking the RNA polymerase II CTD code. , 2008, Trends in genetics : TIG.

[61]  S. Masich,et al.  In situ transcription and splicing in the Balbiani ring 3 gene , 2001, The EMBO journal.

[62]  A. Krainer,et al.  SR proteins function in coupling RNAP II transcription to pre-mRNA splicing. , 2007, Molecular cell.

[63]  B. Frey,et al.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing , 2008, Nature Genetics.

[64]  M. Garcia-Blanco,et al.  The Carboxyl-terminal Domain of RNA Polymerase II Is Not Sufficient to Enhance the Efficiency of Pre-mRNA Capping or Splicing in the Context of a Different Polymerase* , 2009, Journal of Biological Chemistry.

[65]  G. Ast,et al.  Chromatin organization marks exon-intron structure , 2009, Nature Structural &Molecular Biology.

[66]  S. Berget,et al.  Participation of the C-Terminal Domain of RNA Polymerase II in Exon Definition during Pre-mRNA Splicing , 2000, Molecular and Cellular Biology.

[67]  J. Manley,et al.  Concurrent splicing and transcription are not sufficient to enhance splicing efficiency. , 2007, RNA.

[68]  Eric T. Wang,et al.  Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.

[69]  D. Bentley,et al.  "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions. , 2009, Molecular cell.

[70]  J. Ross,et al.  Dilated cardiomyopathy caused by tissue‐specific ablation of SC35 in the heart , 2004, The EMBO journal.

[71]  Dirk Eick,et al.  TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. , 2009, Molecular cell.

[72]  A. Kornblihtt,et al.  Promoter usage and alternative splicing. , 2005, Current opinion in cell biology.

[73]  D. Bentley,et al.  Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. , 2005, Current opinion in cell biology.

[74]  D. Bentley,et al.  RNA Polymerase II Carboxy-Terminal Domain Phosphorylation Is Required for Cotranscriptional Pre-mRNA Splicing and 3′-End Formation , 2004, Molecular and Cellular Biology.

[75]  H. Phatnani,et al.  Phosphorylation and functions of the RNA polymerase II CTD. , 2006, Genes & development.

[76]  A. Kornblihtt,et al.  Transcriptional Activators Differ in Their Abilities to Control Alternative Splicing* , 2002, The Journal of Biological Chemistry.

[77]  A. Kornblihtt,et al.  Multiple links between transcription and splicing. , 2004, RNA.

[78]  J. Manley,et al.  Inactivation of the SR Protein Splicing Factor ASF/SF2 Results in Genomic Instability , 2005, Cell.

[79]  Bert W O'Malley,et al.  Coordinate Regulation of Transcription and Splicing by Steroid Receptor Coregulators , 2002, Science.

[80]  D. Bentley,et al.  5'-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. , 1997, Genes & development.

[81]  Dirk Eick,et al.  The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability. , 2004, Nucleic acids research.

[82]  M. Carmo-Fonseca,et al.  The CTD role in cotranscriptional RNA processing and surveillance , 2008, FEBS letters.

[83]  Anton Meinhart,et al.  Recognition of RNA polymerase II carboxy-terminal domain by 3′-RNA-processing factors , 2004, Nature.

[84]  A. Kornblihtt,et al.  Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. , 1999, Molecular cell.

[85]  R. Reed,et al.  Functional coupling of RNAP II transcription to spliceosome assembly. , 2006, Genes & development.

[86]  Jean Y. J. Wang,et al.  Nuclear c-Abl Is a COOH-Terminal Repeated Domain (CTD)-Tyrosine Kinase-specific for the Mammalian RNA Polymerase II: Possible Role in Transcription Elongation , 1999 .

[87]  I. Poser,et al.  SR protein family members display diverse activities in the formation of nascent and mature mRNPs in vivo. , 2009, Molecular cell.

[88]  M. Hagmann,et al.  RNA polymerase II C-terminal domain required for enhancer-driven transcription , 1995, Nature.

[89]  B. Blencowe,et al.  Regulation of Alternative Splicing by Histone Modifications , 2010, Science.